Neo-T (BGI Genomics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNeo-T (BGI Genomics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionT-cell receptor modulators
TargetsT-cell receptor
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBgi Genomics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBgi Genomics Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A